BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21466427)

  • 1. Triterpenoids for cancer prevention and treatment: current status and future prospects.
    Patlolla JM; Rao CV
    Curr Pharm Biotechnol; 2012 Jan; 13(1):147-55. PubMed ID: 21466427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer.
    Shanmugam MK; Nguyen AH; Kumar AP; Tan BK; Sethi G
    Cancer Lett; 2012 Jul; 320(2):158-70. PubMed ID: 22406826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer.
    Bishayee A; Ahmed S; Brankov N; Perloff M
    Front Biosci (Landmark Ed); 2011 Jan; 16(3):980-96. PubMed ID: 21196213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Product Triterpenoids and Their Semi-Synthetic Derivatives with Potential Anticancer Activity.
    Ren Y; Kinghorn AD
    Planta Med; 2019 Aug; 85(11-12):802-814. PubMed ID: 30658371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive Pentacyclic Triterpenes Trigger Multiple Signalling Pathways for Selective Apoptosis Leading to Anticancer Efficacy: Recent Updates and Future Perspectives.
    Banerjee J; Samanta S; Ahmed R; Dash SK
    Curr Protein Pept Sci; 2023; 24(10):820-842. PubMed ID: 37073661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives.
    Parikh NR; Mandal A; Bhatia D; Siveen KS; Sethi G; Bishayee A
    Phytochem Rev; 2014 Dec; 13(4):793-810. PubMed ID: 25395898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy.
    Laszczyk MN
    Planta Med; 2009 Dec; 75(15):1549-60. PubMed ID: 19742422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer.
    Liby KT; Yore MM; Sporn MB
    Nat Rev Cancer; 2007 May; 7(5):357-69. PubMed ID: 17446857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
    Salvador JAR; Leal AS; Valdeira AS; Gonçalves BMF; Alho DPS; Figueiredo SAC; Silvestre SM; Mendes VIS
    Eur J Med Chem; 2017 Dec; 142():95-130. PubMed ID: 28754470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics/epigenomics of triterpenoids in cancer prevention and in health.
    Li S; Kuo HD; Yin R; Wu R; Liu X; Wang L; Hudlikar R; Peter RM; Kong AN
    Biochem Pharmacol; 2020 May; 175():113890. PubMed ID: 32119837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plant-derived triterpenoids as potential antineoplastic agents.
    Setzer WN; Setzer MC
    Mini Rev Med Chem; 2003 Sep; 3(6):540-56. PubMed ID: 12871157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer chemopreventive activity of lupane- and oleanane-type triterpenoids from the cones of Liquidamber styraciflua.
    Fukuda Y; Sakai K; Matsunaga S; Tokuda H; Tanaka R
    Chem Biodivers; 2005 Mar; 2(3):421-8. PubMed ID: 17191990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triterpenoids of marine origin as anti-cancer agents.
    Li YX; Himaya SW; Kim SK
    Molecules; 2013 Jul; 18(7):7886-909. PubMed ID: 23884125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maslinic acid as an effective anticancer agent.
    Lin X; Ozbey U; Sabitaliyevich UY; Attar R; Ozcelik B; Zhang Y; Guo M; Liu M; Alhewairini SS; Farooqi AA
    Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):87-91. PubMed ID: 30084808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol: a review of preclinical studies for human cancer prevention.
    Athar M; Back JH; Tang X; Kim KH; Kopelovich L; Bickers DR; Kim AL
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):274-83. PubMed ID: 17306316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berry fruits for cancer prevention: current status and future prospects.
    Seeram NP
    J Agric Food Chem; 2008 Feb; 56(3):630-5. PubMed ID: 18211019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursolic acid a promising candidate in the therapeutics of breast cancer: Current status and future implications.
    Iqbal J; Abbasi BA; Ahmad R; Mahmood T; Kanwal S; Ali B; Khalil AT; Shah SA; Alam MM; Badshah H
    Biomed Pharmacother; 2018 Dec; 108():752-756. PubMed ID: 30248543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer activities of cranberry phytochemicals: an update.
    Neto CC; Amoroso JW; Liberty AM
    Mol Nutr Food Res; 2008 Jun; 52 Suppl 1():S18-27. PubMed ID: 18504707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis.
    Sinha S; Khan S; Shukla S; Lakra AD; Kumar S; Das G; Maurya R; Meeran SM
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):41-56. PubMed ID: 27210504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.
    Krishnan AV; Feldman D
    Annu Rev Pharmacol Toxicol; 2011; 51():311-36. PubMed ID: 20936945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.